Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies

Molecular Oncology

Volumn 10, Issue 3, 2016, Pages 494-502

  Heitzer, Ellen ^a   Ulz, Peter ^a   Geigl, Jochen B ^a   Speicher, Michael R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Circulating tumor cells (CTCs); Circulating tumor DNA (ctDNA); Plasma DNA; Somatic copy number alterations; Whole genome sequencing

Indexed keywords

CIRCULATING TUMOR DNA; DNA; DNA FRAGMENT; GENOMIC DNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; BREAST CANCER; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME ARM; CIRCULATING TUMOR CELL; COLORECTAL CARCINOMA; COPY NUMBER VARIATION; DNA SEQUENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOME; HAPLOINSUFFICIENCY; HUMAN; KARYOTYPE; LIQUID BIOPSY; LIVER CELL CARCINOMA; MONONUCLEAR CELL; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; OVARY CANCER; PHENOTYPE; POLYPLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOMATIC COPY NUMBER ALTERATION; SOMATIC MUTATION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; BIOPSY; BLOOD; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; PATHOLOGY; TUMOR EMBOLISM;

ANIMALS; BIOPSY; DNA, NEOPLASM; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; SEQUENCE ANALYSIS, DNA;

EID: 84959075341     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.12.004     Document Type: Review

References (75)

1. Alix-Panabieres C., Pantel K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 2014, 14:623-631.
2. Amant F., Verheecke M., Wlodarska I., Dehaspe L., Brady P., Brison N., Van Den Bogaert K., Dierickx D., Vandecaveye V., Tousseyn T., Moerman P., Vanderstichele A., Vergote I., Neven P., Berteloot P., Putseys K., Danneels L., Vandenberghe P., Legius E., Vermeesch J.R. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015, 1:814-819.
3. Baslan T., Kendall J., Rodgers L., Cox H., Riggs M., Stepansky A., Troge J., Ravi K., Esposito D., Lakshmi B., Wigler M., Navin N., Hicks J. Genome-wide copy number analysis of single cells. Nat. Protoc. 2012, 7:1024-1041.
4. Baslan T., Kendall J., Ward B., Cox H., Leotta A., Rodgers L., Riggs M., D'Italia S., Sun G., Yong M., Miskimen K., Gilmore H., Saborowski M., Dimitrova N., Krasnitz A., Harris L., Wigler M., Hicks J. Optimizing sparse sequencing of single cells for highly multiplex copy number profiling. Genome Res. 2015, 25:714-724.
5. Belic J., Koch M., Ulz P., Auer M., Gerhalter T., Mohan S., Fischereder K., Petru E., Bauernhofer T., Geigl J.B., Speicher M.R., Heitzer E. Rapid identification of plasma DNA samples with increased ctDNA levels by a modified FAST-SeqS approach. Clin. Chem. 2015, 61:838-849.
6. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y.J., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
7. Bettegowda C., Sausen M., Leary R.J., Kinde I., Wang Y., Agrawal N., Bartlett B.R., Wang H., Luber B., Alani R.M., Antonarakis E.S., Azad N.S., Bardelli A., Brem H., Cameron J.L., Lee C.C., Fecher L.A., Gallia G.L., Gibbs P., Le D., Giuntoli R.L., Goggins M., Hogarty M.D., Holdhoff M., Hong S.M., Jiao Y., Juhl H.H., Kim J.J., Siravegna G., Laheru D.A., Lauricella C., Lim M., Lipson E.J., Marie S.K., Netto G.J., Oliner K.S., Olivi A., Olsson L., Riggins G.J., Sartore-Bianchi A., Schmidt K., Shih l.M., Oba-Shinjo S.M., Siena S., Theodorescu D., Tie J., Harkins T.T., Veronese S., Wang T.L., Weingart J.D., Wolfgang C.L., Wood L.D., Xing D., Hruban R.H., Wu J., Allen P.J., Schmidt C.M., Choti M.A., Velculescu V.E., Kinzler K.W., Vogelstein B., Papadopoulos N., Diaz L.A. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 2014, 6:224ra224.
8. Bianchi D.W., Chudova D., Sehnert A.J., Bhatt S., Murray K., Prosen T.L., Garber J.E., Wilkins-Haug L., Vora N.L., Warsof S., Goldberg J., Ziainia T., Halks-Miller M. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA: J. Am. Med. Assoc. 2015, 314:162-169.
9. Carreira S., Romanel A., Goodall J., Grist E., Ferraldeschi R., Miranda S., Prandi D., Lorente D., Frenel J.S., Pezaro C., Omlin A., Rodrigues D.N., Flohr P., Tunariu N., de Bono J.S., Demichelis F., Attard G. Tumor clone dynamics in lethal prostate cancer. Sci. Transl. Med. 2014, 6:254ra125.
10. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 2006, 38:1043-1048.
11. Chan K.C., Jiang P., Chan C.W., Sun K., Wong J., Hui E.P., Chan S.L., Chan W.C., Hui D.S., Ng S.S., Chan H.L., Wong C.S., Ma B.B., Chan A.T., Lai P.B., Sun H., Chiu R.W., Lo Y.M. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:18761-18768.
12. Chan K.C., Jiang P., Zheng Y.W., Liao G.J., Sun H., Wong J., Siu S.S., Chan W.C., Chan S.L., Chan A.T., Lai P.B., Chiu R.W., Lo Y.M. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin. Chem. 2013, 59:211-224.
13. Cherny N.I., de Vries E.G., Emanuel L., Fallowfield L., Francis P.A., Gabizon A., Piccart M.J., Sidransky D., Soussan-Gutman L., Tziraki C. Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics". J. Natl. Cancer Inst. 2014, 106.
14. Chiu R.W., Lo Y.M. Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research. Clin. Chem. Lab. Med.: CCLM/FESCC 2012, 0:1-8.
15. Chiu R.W., Chan K.C., Gao Y., Lau V.Y., Zheng W., Leung T.Y., Foo C.H., Xie B., Tsui N.B., Lun F.M., Zee B.C., Lau T.K., Cantor C.R., Lo Y.M. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20458-20463.
16. Chiu C.G., Nakamura Y., Chong K.K., Huang S.K., Kawas N.P., Triche T., Elashoff D., Kiyohara E., Irie R.F., Morton D.L., Hoon D.S. Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clin. Chem. 2014, 60:873-885.
17. Crowley E., Di Nicolantonio F., Loupakis F., Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 2013, 10:472-484.
18. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., Graf S., Ha G., Haffari G., Bashashati A., Russell R., McKinney S., Group M., Langerod A., Green A., Provenzano E., Wishart G., Pinder S., Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Borresen-Dale A.L., Brenton J.D., Tavare S., Caldas C., Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
19. Davoli T., Xu A.W., Mengwasser K.E., Sack L.M., Yoon J.C., Park P.J., Elledge S.J. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 2013, 155:948-962.
20. Dawson S.J., Tsui D.W., Murtaza M., Biggs H., Rueda O.M., Chin S.F., Dunning M.J., Gale D., Forshew T., Mahler-Araujo B., Rajan S., Humphray S., Becq J., Halsall D., Wallis M., Bentley D., Caldas C., Rosenfeld N. Analysis of circulating tumor DNA to monitor metastatic breast cancer. New Engl. J. Med. 2013, 368:1199-1209.
21. Diaz L.A., Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2014, 32:579-586.
22. Diaz L.A., Williams R.T., Wu J., Kinde I., Hecht J.R., Berlin J., Allen B., Bozic I., Reiter J.G., Nowak M.A., Kinzler K.W., Oliner K.S., Vogelstein B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012, 486:537-540.
23. Diehl F., Li M., Dressman D., He Y., Shen D., Szabo S., Diaz L.A., Goodman S.N., David K.A., Juhl H., Kinzler K.W., Vogelstein B. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16368-16373.
24. Diehl F., Schmidt K., Choti M.A., Romans K., Goodman S., Li M., Thornton K., Agrawal N., Sokoll L., Szabo S.A., Kinzler K.W., Vogelstein B., Diaz L.A. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 2008, 14:985-990.
25. Diehl F., Schmidt K., Durkee K.H., Moore K.J., Goodman S.N., Shuber A.P., Kinzler K.W., Vogelstein B. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 2008, 135:489-498.
26. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16266-16271.
27. Fiegler H., Geigl J.B., Langer S., Rigler D., Porter K., Unger K., Carter N.P., Speicher M.R. High resolution array-CGH analysis of single cells. Nucleic Acids Res. 2007, 35:e15.
28. Forshew T., Murtaza M., Parkinson C., Gale D., Tsui D.W., Kaper F., Dawson S.J., Piskorz A.M., Jimenez-Linan M., Bentley D., Hadfield J., May A.P., Caldas C., Brenton J.D., Rosenfeld N. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 2012, 4:136ra168.
29. Garvin T., Aboukhalil R., Kendall J., Baslan T., Atwal G.S., Hicks J., Wigler M., Schatz M.C. Interactive analysis and assessment of single-cell copy-number variations. Nat. Methods 2015, 12:1058-1060.
30. Geigl J.B., Speicher M.R. Single-cell isolation from cell suspensions and whole genome amplification from single cells to provide templates for CGH analysis. Nat. Protoc. 2007, 2:3173-3184.
31. Geigl J.B., Obenauf A.C., Schwarzbraun T., Speicher M.R. Defining 'chromosomal instability'. Trends Genet.: TIG 2008, 24:64-69.
32. Geigl J.B., Obenauf A.C., Waldispuehl-Geigl J., Hoffmann E.M., Auer M., Hormann M., Fischer M., Trajanoski Z., Schenk M.A., Baumbusch L.O., Speicher M.R. Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res. 2009, 37:e105.
33. Grasso C.S., Wu Y.M., Robinson D.R., Cao X., Dhanasekaran S.M., Khan A.P., Quist M.J., Jing X., Lonigro R.J., Brenner J.C., Asangani I.A., Ateeq B., Chun S.Y., Siddiqui J., Sam L., Anstett M., Mehra R., Prensner J.R., Palanisamy N., Ryslik G.A., Vandin F., Raphael B.J., Kunju L.P., Rhodes D.R., Pienta K.J., Chinnaiyan A.M., Tomlins S.A. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012, 487:239-243.
34. Heidary M., Auer M., Ulz P., Heitzer E., Petru E., Gasch C., Riethdorf S., Mauermann O., Lafer I., Pristauz G., Lax S., Pantel K., Geigl J.B., Speicher M.R. The dynamic range of circulating tumor DNA in metastatic breast cancer. Breast Cancer Res.: BCR 2014, 16:421.
35. Heitzer E., Auer M., Gasch C., Pichler M., Ulz P., Hoffmann E.M., Lax S., Waldispuehl-Geigl J., Mauermann O., Lackner C., Hofler G., Eisner F., Sill H., Samonigg H., Pantel K., Riethdorf S., Bauernhofer T., Geigl J.B., Speicher M.R. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 2013, 73:2965-2975.
36. Heitzer E., Auer M., Hoffmann E.M., Pichler M., Gasch C., Ulz P., Lax S., Waldispuehl-Geigl J., Mauermann O., Mohan S., Pristauz G., Lackner C., Hofler G., Eisner F., Petru E., Sill H., Samonigg H., Pantel K., Riethdorf S., Bauernhofer T., Geigl J.B., Speicher M.R. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int. J. Cancer 2013, 133:346-356.
37. Heitzer E., Auer M., Ulz P., Geigl J.B., Speicher M.R. Circulating tumor cells and DNA as liquid biopsies. Genome Med. 2013, 5:73.
38. Heitzer E., Ulz P., Belic J., Gutschi S., Quehenberger F., Fischereder K., Benezeder T., Auer M., Pischler C., Mannweiler S., Pichler M., Eisner F., Haeusler M., Riethdorf S., Pantel K., Samonigg H., Hoefler G., Augustin H., Geigl J.B., Speicher M.R. Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Med. 2013, 5:30.
39. Heitzer E., Ulz P., Geigl J.B. Circulating tumor DNA as a liquid biopsy for cancer. Clin. Chem. 2015, 61:112-123.
40. Knudson A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 2001, 1:157-162.
41. Leary R.J., Kinde I., Diehl F., Schmidt K., Clouser C., Duncan C., Antipova A., Lee C., McKernan K., De La Vega F.M., Kinzler K.W., Vogelstein B., Diaz L.A., Velculescu V.E. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2010, 2:20ra14.
42. Leary R.J., Sausen M., Kinde I., Papadopoulos N., Carpten J.D., Craig D., O'Shaughnessy J., Kinzler K.W., Parmigiani G., Vogelstein B., Diaz L.A., Velculescu V.E. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci. Transl. Med. 2012, 4:162ra154.
43. Magbanua M.J., Sosa E.V., Roy R., Eisenbud L.E., Scott J.H., Olshen A., Pinkel D., Rugo H.S., Park J.W. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res. 2013, 73:30-40.
44. Mazel M., Jacot W., Pantel K., Bartkowiak K., Topart D., Cayrefourcq L., Rossille D., Maudelonde T., Fest T., Alix-Panabieres C. Frequent expression of PD-L1 on circulating breast cancer cells. Mol. Oncol. 2015, 9:1773-1782.
45. McBride D.J., Orpana A.K., Sotiriou C., Joensuu H., Stephens P.J., Mudie L.J., Hamalainen E., Stebbings L.A., Andersson L.C., Flanagan A.M., Durbecq V., Ignatiadis M., Kallioniemi O., Heckman C.A., Alitalo K., Edgren H., Futreal P.A., Stratton M.R., Campbell P.J. Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer 2010, 49:1062-1069.
46. Misale S., Yaeger R., Hobor S., Scala E., Janakiraman M., Liska D., Valtorta E., Schiavo R., Buscarino M., Siravegna G., Bencardino K., Cercek A., Chen C.T., Veronese S., Zanon C., Sartore-Bianchi A., Gambacorta M., Gallicchio M., Vakiani E., Boscaro V., Medico E., Weiser M., Siena S., Di Nicolantonio F., Solit D., Bardelli A. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012, 486:532-536.
47. Misale S., Arena S., Lamba S., Siravegna G., Lallo A., Hobor S., Russo M., Buscarino M., Lazzari L., Sartore-Bianchi A., Bencardino K., Amatu A., Lauricella C., Valtorta E., Siena S., Di Nicolantonio F., Bardelli A. Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer. Sci. Transl. Med. 2014, 6:224ra226.
48. Mohan S., Heitzer E., Ulz P., Lafer I., Lax S., Auer M., Pichler M., Gerger A., Eisner F., Hoefler G., Bauernhofer T., Geigl J.B., Speicher M.R. Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. PLoS Genet. 2014, 10:e1004271.
49. Mohlendick B., Bartenhagen C., Behrens B., Honisch E., Raba K., Knoefel W.T., Stoecklein N.H. A robust method to analyze copy number alterations of less than 100 kb in single cells using oligonucleotide array CGH. PloS One 2013, 8:e67031.
50. Murtaza M., Dawson S.J., Tsui D.W., Gale D., Forshew T., Piskorz A.M., Parkinson C., Chin S.F., Kingsbury Z., Wong A.S., Marass F., Humphray S., Hadfield J., Bentley D., Chin T.M., Brenton J.D., Caldas C., Rosenfeld N. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013, 497:108-112.
51. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., Cook K., Stepansky A., Levy D., Esposito D., Muthuswamy L., Krasnitz A., McCombie W.R., Hicks J., Wigler M. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
52. Nawroz H., Koch W., Anker P., Stroun M., Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 1996, 2:1035-1037.
53. Neves R.P., Raba K., Schmidt O., Honisch E., Meier-Stiegen F., Behrens B., Mohlendick B., Fehm T., Neubauer H., Klein C.A., Polzer B., Sproll C., Fischer J.C., Niederacher D., Stoecklein N.H. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer. Clin. Chem. 2014, 60:1290-1297.
54. Newman A.M., Bratman S.V., To J., Wynne J.F., Eclov N.C., Modlin L.A., Liu C.L., Neal J.W., Wakelee H.A., Merritt R.E., Shrager J.B., Loo B.W., Alizadeh A.A., Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 2014, 20:548-554.
55. Ni X., Zhuo M., Su Z., Duan J., Gao Y., Wang Z., Zong C., Bai H., Chapman A.R., Zhao J., Xu L., An T., Ma Q., Wang Y., Wu M., Sun Y., Wang S., Li Z., Yang X., Yong J., Su X.D., Lu Y., Bai F., Xie X.S., Wang J. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:21083-21088.
56. Olsson E., Winter C., George A., Chen Y., Howlin J., Tang M.H., Dahlgren M., Schulz R., Grabau D., van Westen D., Ferno M., Ingvar C., Rose C., Bendahl P.O., Ryden L., Borg A., Gruvberger-Saal S.K., Jernstrom H., Saal L.H. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Med. 2015, 7:1034-1047.
57. Pantel K., Speicher M.R. The biology of circulating tumor cells. Oncogene 2015, 10.1038/onc.2015.192.
58. Polzer B., Medoro G., Pasch S., Fontana F., Zorzino L., Pestka A., Andergassen U., Meier-Stiegen F., Czyz Z.T., Alberter B., Treitschke S., Schamberger T., Sergio M., Bregola G., Doffini A., Gianni S., Calanca A., Signorini G., Bolognesi C., Hartmann A., Fasching P.A., Sandri M.T., Rack B., Fehm T., Giorgini G., Manaresi N., Klein C.A. Molecular profiling of single circulating tumor cells with diagnostic intention. EMBO Mol. Med. 2014, 6:1371-1386.
59. Reinert T., Scholer L.V., Thomsen R., Tobiasen H., Vang S., Nordentoft I., Lamy P., Kannerup A.S., Mortensen F.V., Stribolt K., Hamilton-Dutoit S., Nielsen H.J., Laurberg S., Pallisgaard N., Pedersen J.S., Orntoft T.F., Andersen C.L. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut 2015, 10.1136/gutjnl-2014-308859.
60. Santaguida S., Amon A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat. Rev. Mol. Cell Biol. 2015, 16:473-485.
61. Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 2011, 11:426-437.
62. Shaw J.A., Page K., Blighe K., Hava N., Guttery D., Ward B., Brown J., Ruangpratheep C., Stebbing J., Payne R., Palmieri C., Cleator S., Walker R.A., Coombes R.C. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 2012, 22:220-231.
63. Siravegna G., Mussolin B., Buscarino M., Corti G., Cassingena A., Crisafulli G., Ponzetti A., Cremolini C., Amatu A., Lauricella C., Lamba S., Hobor S., Avallone A., Valtorta E., Rospo G., Medico E., Motta V., Antoniotti C., Tatangelo F., Bellosillo B., Veronese S., Budillon A., Montagut C., Racca P., Marsoni S., Falcone A., Corcoran R.B., Di Nicolantonio F., Loupakis F., Siena S., Sartore-Bianchi A., Bardelli A. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015, 21:795-801.
64. Solimini N.L., Xu Q., Mermel C.H., Liang A.C., Schlabach M.R., Luo J., Burrows A.E., Anselmo A.N., Bredemeyer A.L., Li M.Z., Beroukhim R., Meyerson M., Elledge S.J. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 2012, 337:104-109.
65. Steinert G., Scholch S., Niemietz T., Iwata N., Garcia S.A., Behrens B., Voigt A., Kloor M., Benner A., Bork U., Rahbari N.N., Buchler M.W., Stoecklein N.H., Weitz J., Koch M. Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res. 2014, 74:1694-1704.
66. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
67. Sun K., Jiang P., Chan K.C., Wong J., Cheng Y.K., Liang R.H., Chan W.K., Ma E.S., Chan S.L., Cheng S.H., Chan R.W., Tong Y.K., Ng S.S., Wong R.S., Hui D.S., Leung T.N., Leung T.Y., Lai P.B., Chiu R.W., Lo Y.M. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E5503-E5512.
68. Taylor B.S., Schultz N., Hieronymus H., Gopalan A., Xiao Y., Carver B.S., Arora V.K., Kaushik P., Cerami E., Reva B., Antipin Y., Mitsiades N., Landers T., Dolgalev I., Major J.E., Wilson M., Socci N.D., Lash A.E., Heguy A., Eastham J.A., Scher H.I., Reuter V.E., Scardino P.T., Sander C., Sawyers C.L., Gerald W.L. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
69. Thierry A.R., Mouliere F., El Messaoudi S., Mollevi C., Lopez-Crapez E., Rolet F., Gillet B., Gongora C., Dechelotte P., Robert B., Del Rio M., Lamy P.J., Bibeau F., Nouaille M., Loriot V., Jarrousse A.S., Molina F., Mathonnet M., Pezet D., Ychou M. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat. Med. 2014, 20:430-435.
70. Valtorta E., Misale S., Sartore-Bianchi A., Nagtegaal I.D., Paraf F., Lauricella C., Dimartino V., Hobor S., Jacobs B., Ercolani C., Lamba S., Scala E., Veronese S., Laurent-Puig P., Siena S., Tejpar S., Mottolese M., Punt C.J., Gambacorta M., Bardelli A., Di Nicolantonio F. KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. Int. J. Cancer 2013, 133:1259-1265.
71. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
72. Wang T.L., Maierhofer C., Speicher M.R., Lengauer C., Vogelstein B., Kinzler K.W., Velculescu V.E. Digital karyotyping. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16156-16161.
73. Xia S., Kohli M., Du M., Dittmar R.L., Lee A., Nandy D., Yuan T., Guo Y., Wang Y., Tschannen M.R., Worthey E., Jacob H., See W., Kilari D., Wang X., Hovey R.L., Huang C.C., Wang L. Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. Oncotarget 2015, 6:16411-16421.
74. Yung T.K., Chan K.C., Mok T.S., Tong J., To K.F., Lo Y.M. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin. Cancer Res. 2009, 15:2076-2084.
75. Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., Lawrence M.S., Zhang C.Z., Wala J., Mermel C.H., Sougnez C., Gabriel S.B., Hernandez B., Shen H., Laird P.W., Getz G., Meyerson M., Beroukhim R. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 2013, 45:1134-1140.